BioCentury | Nov 30, 2018
Company News

CBT, Bossan partner for combination trials

...CBT Pharmaceuticals Inc. (Pleasanton, Calif.) gained exclusive, worldwide rights to develop and commercialize EGFR inhibitor ES-072...
...Co. Ltd. (Hangzhou, China). CBT and Bossan will jointly develop and conduct clinical trials for ES-072...
Items per page:
1 - 1 of 1